Feed mill to produce 422,000 tonnes annually.
The Saumon du Médoc facility
The acquisition builds on Boehringer Ingelheim’s broader investment in therapeutic vaccines.
Novonesis has not disclosed an expected closing date.
The acquisition combines 2 family-owned fermentation and enzyme technology companies, adding manufacturing capacity.
The acquisition adds a leading, clinically studied muscle health brand and its patented Fortetropin® ingredient technology to PetIQ.
The deal will add biotechnology products and technical expertise to Innovad Group’s business in Brazil while supporting its plans across Latin America.
The new facility will bring together the company’s regional business functions and strengthen its pipeline of animal nutrition solutions across the region.
The project aims to reach 30,000 smallholder dairy farmers over a nine-month pilot period.
Major international companies, including Andritz Feed & Biofuel, Cargill, Charoen Pokphand Indonesia, Famsun, EW Nutrition, Elanco, Evonik, Olmix, ADM Protexin and Angel Yeast, showcased innovations.